ATE321132T1 - Methode zur herstellung einer immunotropischen antiviralen zusammensetzung - Google Patents

Methode zur herstellung einer immunotropischen antiviralen zusammensetzung

Info

Publication number
ATE321132T1
ATE321132T1 AT01930355T AT01930355T ATE321132T1 AT E321132 T1 ATE321132 T1 AT E321132T1 AT 01930355 T AT01930355 T AT 01930355T AT 01930355 T AT01930355 T AT 01930355T AT E321132 T1 ATE321132 T1 AT E321132T1
Authority
AT
Austria
Prior art keywords
solution
dna
hyperchromatic
homogenate
detergent
Prior art date
Application number
AT01930355T
Other languages
English (en)
Inventor
Elli Nikolaevna Kaplina
Alexandra Yurievna Ladygina
Valery Yurievich Kaplin
Mihail Yurievich Vainberg
Original Assignee
Elli Nikolaevna Kaplina
Alexandra Yurievna Ladygina
Valery Yurievich Kaplin
Mihail Yurievich Vainberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20242805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE321132(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elli Nikolaevna Kaplina, Alexandra Yurievna Ladygina, Valery Yurievich Kaplin, Mihail Yurievich Vainberg filed Critical Elli Nikolaevna Kaplina
Application granted granted Critical
Publication of ATE321132T1 publication Critical patent/ATE321132T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01930355T 2000-12-01 2001-04-24 Methode zur herstellung einer immunotropischen antiviralen zusammensetzung ATE321132T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000130036/14A RU2172632C1 (ru) 2000-12-01 2000-12-01 Способ получения иммунотропного противовирусного препарата

Publications (1)

Publication Number Publication Date
ATE321132T1 true ATE321132T1 (de) 2006-04-15

Family

ID=20242805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01930355T ATE321132T1 (de) 2000-12-01 2001-04-24 Methode zur herstellung einer immunotropischen antiviralen zusammensetzung

Country Status (8)

Country Link
EP (1) EP1338281B1 (de)
AT (1) ATE321132T1 (de)
AU (1) AU2001256888A1 (de)
BR (1) BR0107998A (de)
CA (1) CA2399310C (de)
DE (1) DE60118175T2 (de)
RU (1) RU2172632C1 (de)
WO (1) WO2002043740A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2236853C1 (ru) * 2003-12-30 2004-09-27 Каплина Элли Николаевна Способ производства иммунотропного стерильного апирогенного толерантного препарата на основе натриевой соли низкомолекулярной нативной дезоксирибонуклеиновой кислоты
RU2268730C1 (ru) * 2004-04-26 2006-01-27 Общество с ограниченной ответственностью "БиоМодуль" Способ получения натриевой соли гетерогенной дезоксирибонуклеиновой кислоты (днк)
RU2309759C1 (ru) * 2006-11-03 2007-11-10 Элли Николаевна Каплина Способ получения апирогенного иммуномодулятора
RU2519349C1 (ru) * 2013-02-26 2014-06-10 Государственное научное учреждение Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии Российской академии сельскохозяйственных наук (ГНУ ВНИВИПФиТ Россельхозакадемии) Способ комплексного лечения мастита у лактирующих коров
RU2739186C1 (ru) * 2020-04-21 2020-12-21 Александр Евгеньевич Ладыгин Способ получения противовирусного лекарственного средства

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ209840A (en) * 1983-10-17 1988-11-29 Kaji Akira A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
US5380830A (en) * 1989-09-18 1995-01-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Molecular clones of bovine immunodeficiency-like virus
WO1993010793A1 (fr) * 1991-12-03 1993-06-10 Jury Petrovich Vainberg Agent antiviral
US5547684A (en) * 1993-02-10 1996-08-20 Pharmec Company Cosmetic composition containing a DNA-sodium salt and methods of making and using the same
RU2005724C1 (ru) * 1993-04-29 1994-01-15 Юрий Петрович Вайнберг Способ производства натриевой соли дезоксирибонуклеиновой кислоты из животного сырья и установка для его осуществления
RU2043767C1 (ru) * 1993-05-24 1995-09-20 Научно-производственное предприятие "Фармэк" Способ подавления вич-инфекции
AU6584994A (en) * 1993-05-24 1994-12-20 Nauchno-Proizvodstvennoe Predpriyatie "Farmek" Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
RU2041885C1 (ru) * 1993-05-31 1995-08-20 Научно-производственный центр "Фармзащита" МЗ РФ Способ получения порошка натриевой соли дезоксирибонуклеиновой кислоты из молок рыб
RU2055837C1 (ru) * 1994-05-31 1996-03-10 Научно-производственный центр "Фармзащита" Способ получения стерильного раствора натриевой соли дезоксирибонуклеиновой кислоты
WO1996009832A1 (en) * 1994-09-29 1996-04-04 Nauchno-Proizvodstvennoe Predpriyatie 'farmek' Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid
RU2108797C1 (ru) * 1994-11-09 1998-04-20 Закрытое акционерное общество "Фаркавер" Способ получения антивирусного препарата на основе днк
RU2136286C1 (ru) * 1996-01-22 1999-09-10 Каплина Элли Николаевна Противовирусное средство к рнк- и днк-содержащим вирусам
RU2158592C1 (ru) * 1999-12-29 2000-11-10 Каплина Элли Николаевна Противовирусное иммунотропное средство

Also Published As

Publication number Publication date
DE60118175T2 (de) 2007-01-25
WO2002043740A1 (en) 2002-06-06
BR0107998A (pt) 2002-10-29
CA2399310C (en) 2012-09-18
EP1338281B1 (de) 2006-03-22
AU2001256888A1 (en) 2002-06-11
CA2399310A1 (en) 2002-06-06
EP1338281A4 (de) 2004-03-24
EP1338281A1 (de) 2003-08-27
DE60118175D1 (de) 2006-05-11
RU2172632C1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
DE69919019D1 (de) Verfahren zur herstellung einer proteinzusammenzetzung und einer diese enthaltenden säuglingsnahrung
DE60143292D1 (de) Varianten des menschlichen Koagulationsfaktors VII
EP2039769A3 (de) Antimikrobielle Peptide und Verwendungsverfahren
ATE347910T1 (de) Zusammensetzungen zur behandlung von ischamischem gewebe
AR014261A1 (es) Compuestos hipolipidemicos de benzotiazepina, composiciones y proceso para su preparacion
KR890004725A (ko) 신규 방법
MXPA03009408A (es) Factor de crecimiento endotelial vascular 2.
DE69418403D1 (de) Verfahren zur Herstellung von Aminosäureteilchen
ATA162991A (de) Verfahren zur inaktivierung von prionen
BR9910490A (pt) Materiais e métodos para criar insetos, ácaros e outros organismos benéficos
PT94680A (pt) Processo para a obtencao de uma proteina tendo actividade de urato oxidase gene recombinante que a codifica vector de expressao portador deste gene microorganismos procariotas e celulas eucariotas transformados por este vector de expressao
ATE517184T1 (de) Hcv ns3/4a kodierende nukleinsäure
ATE321132T1 (de) Methode zur herstellung einer immunotropischen antiviralen zusammensetzung
WO2004064732A3 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
DE60102147D1 (de) Anti-gefrier proteine, deren herstellung und verwendung
BR0214702A (pt) Métodos e composições para emprego em criação de animal de estimação
PT1140113E (pt) Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos
BR0210522A (pt) Processo para tratamento de carcaça de animal
JP3790671B2 (ja) 人体および動植物生理活性促進物ならびにその製造方法
DE59003273D1 (de) Verfahren zur Herstellung von Protein-Hydrolysaten mit niedrigem Gehalt an Bitterstoffen.
ATE533495T1 (de) Zusammensetzungen zur behandlung von hautkrankheiten gekennzeichnet durch exsudation von serumproteinen
BR0215274A (pt) Alimentos ricos em netionina modificados e processos de sua fabricação
ATE245438T1 (de) Verwendung von oligomerem matrixprotein aus knorpel zur behandlung von rheumatoider arthritis
ATE293891T1 (de) Verfahren zur herstellung von futterstücken aus klärschlamm
ATE421326T1 (de) Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1338281

Country of ref document: EP